Skip to main content
Medical information Clinical review pending

Endocrine Testing

IGF I Growth Hormone Panel Test

The IGF I Growth Hormone Panel Test measures insulin-like growth factor (IGF-I) levels to help evaluate growth disorders, such as growth hormone deficiencies or excesses.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
3 mL (1.5 mL minimum) serum from 1 Serum Separator Tube (SST).
Results
Confirm with the laboratory before booking.
Preparation
Overnight fasting is required. Patients should be at complete rest for 30 minutes before the sample is collected.
Test priceKSh 13,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the IGF I Growth Hormone Panel Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Unexplained growth delays in children
  • ✓Excessive growth or gigantism
  • ✓Short stature in children or adults
  • ✓Suspected growth hormone deficiency
  • ✓Monitoring growth hormone therapy
  • ✓Evaluating pituitary function
02

In plain language

What this test helps you understand

This test helps diagnose conditions related to growth hormone deficiencies or excesses, guiding treatment decisions and monitoring therapy effectiveness for growth disorders.
The IGF I Growth Hormone Panel Test is a diagnostic tool used to assess growth disorders by measuring levels of insulin-like growth factor (IGF-I) in the blood. This test is important for evaluating the functionality of growth hormone and its impact on growth and development in both children and adults.

This test measures the concentration of IGF-I, a hormone produced mainly in the liver in response to growth hormone. IGF-I plays a vital role in growth and development, influencing cellular growth and metabolism.

This test is recommended for individuals experiencing symptoms such as unexplained growth delays in children, excessive growth or gigantism, short stature, or signs of growth hormone deficiency. A family history of growth disorders or previous treatments affecting growth hormone levels may also be risk factors.

Taking this test helps in diagnosing growth hormone deficiencies or excesses, guides treatment decisions for growth disorders, and monitors the effectiveness of ongoing treatment for growth-related conditions.

The results will indicate whether your IGF-I levels are within the normal range. Abnormal levels may suggest growth hormone-related disorders, requiring further investigation or treatment. It is essential to consult your healthcare provider for a thorough interpretation of your results.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationOvernight fasting is required. Patients should be at complete rest for 30 minutes before the sample is collected.
Sample3 mL (1.5 mL minimum) serum from 1 Serum Separator Tube (SST).
MethodologyConfirm with the laboratory before booking.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
IGF-I levels can be influenced by nutritional status, age, and other hormonal factors. Results should be interpreted by a qualified healthcare professional in conjunction with clinical findings.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test measures the level of Insulin-like Growth Factor I (IGF-I) in your blood, which is produced in response to growth hormone.
It helps diagnose growth disorders like growth hormone deficiency or excess, guides treatment, and monitors therapy effectiveness.
Individuals with unexplained growth delays, excessive growth, short stature, or suspected growth hormone issues should consider this test.
Yes, overnight fasting is required. You should also rest for 30 minutes before the sample is collected.
A healthcare provider will interpret your results based on reference ranges and your individual clinical situation.
We have branches across major cities in Kenya. Please call or WhatsApp +254711564616 to book.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp